Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

STACEY BELTZ

Allopathic & Osteopathic Physicians Family Medicine

NPI
1225007255
CMS profile
327907
Location
TROY, MI

General Payments · PY2018–2024

$5,043.86

  • Reported across 321 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$666.04

37 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $666.04 37

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
PFIZER INC. $179.54 10
Novo Nordisk AS $175.87 10
Exact Sciences Corporation $92.42 5
Lilly USA, LLC $86.64 5
Merck Sharp & Dohme Corporation $27.01 1
ABBVIE INC. $22.78 1
GlaxoSmithKline, LLC. $19.88 1
BOSTON SCIENTIFIC CORPORATION $17.65 1
Acerta Pharma LLC $15.30 1
Astellas Pharma US Inc $14.66 1
Amgen Inc. $14.29 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $793.60 58
PY2019 $508.60 43
PY2020 $706.18 49
PY2021 $1,045.64 64
PY2022 $786.34 39
PY2023 $537.46 31
PY2024 $666.04 37

Payment records · PY2024 (37)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $22.78 09/17/2024 Food and Beverage Undisputed 01/23/2026 1103305228 CMS
Amgen Inc. $14.29 10/21/2024 Food and Beverage Undisputed 01/23/2026 1115445976 CMS
Astellas Pharma US Inc $14.66 03/11/2024 Food and Beverage Undisputed 01/23/2026 1139318678 CMS
AstraZeneca Pharmaceuticals LP $15.30 08/27/2024 Food and Beverage Undisputed 01/23/2026 1105400468 CMS
Boston Scientific Corporation $17.65 05/21/2024 Food and Beverage Undisputed 01/23/2026 1092520325 CMS
Exact Sciences Corporation $18.74 01/22/2024 Food and Beverage Undisputed 01/23/2026 1114589461 CMS
Exact Sciences Corporation $16.86 03/18/2024 Food and Beverage Undisputed 01/23/2026 1114589464 CMS
Exact Sciences Corporation $18.34 05/06/2024 Food and Beverage Undisputed 01/23/2026 1114589468 CMS
Exact Sciences Corporation $16.51 06/18/2024 Food and Beverage Undisputed 01/23/2026 1114589472 CMS
Exact Sciences Corporation $21.97 09/16/2024 Food and Beverage Undisputed 01/23/2026 1114589477 CMS
GlaxoSmithKline, LLC. $19.88 11/08/2024 Food and Beverage Undisputed 01/23/2026 1115874929 CMS
Lilly USA, LLC $17.93 02/16/2024 Food and Beverage Undisputed 01/23/2026 1135423431 CMS
Lilly USA, LLC $19.65 04/18/2024 Food and Beverage Undisputed 01/23/2026 1135423429 CMS
Lilly USA, LLC $20.24 05/10/2024 Food and Beverage Undisputed 01/23/2026 1135430327 CMS
Lilly USA, LLC $15.34 05/20/2024 Food and Beverage Undisputed 01/23/2026 1135349531 CMS
Lilly USA, LLC $13.48 09/30/2024 Food and Beverage Undisputed 01/23/2026 1135429043 CMS
Merck Sharp & Dohme LLC $27.01 09/03/2024 Food and Beverage Undisputed 01/23/2026 1141910006 CMS
Novo Nordisk Inc $15.84 01/04/2024 Food and Beverage Undisputed 01/23/2026 1097289351 CMS
Novo Nordisk Inc $16.71 01/08/2024 Food and Beverage Undisputed 01/23/2026 1097440819 CMS
Novo Nordisk Inc $5.22 01/19/2024 Food and Beverage Undisputed 01/23/2026 1096661112 CMS
Novo Nordisk Inc $12.19 01/29/2024 Food and Beverage Undisputed 01/23/2026 1097124494 CMS
Novo Nordisk Inc $21.41 06/04/2024 Food and Beverage Undisputed 01/23/2026 1096707924 CMS
Novo Nordisk Inc $20.73 06/06/2024 Food and Beverage Undisputed 01/23/2026 1097137285 CMS
Novo Nordisk Inc $15.95 08/19/2024 Food and Beverage Undisputed 01/23/2026 1096865329 CMS
Novo Nordisk Inc $22.07 09/30/2024 Food and Beverage Undisputed 01/23/2026 1097082016 CMS
Novo Nordisk Inc $26.07 11/05/2024 Food and Beverage Undisputed 01/23/2026 1096793076 CMS
Novo Nordisk Inc $19.68 12/02/2024 Food and Beverage Undisputed 01/23/2026 1096930576 CMS
PFIZER INC. $16.77 02/12/2024 Food and Beverage Undisputed 01/23/2026 1131061512 CMS
PFIZER INC. $18.75 02/19/2024 Food and Beverage Undisputed 01/23/2026 1131189962 CMS
PFIZER INC. $13.23 02/26/2024 Food and Beverage Undisputed 01/23/2026 1131122163 CMS
PFIZER INC. $16.56 05/20/2024 Food and Beverage Undisputed 01/23/2026 1131501774 CMS
PFIZER INC. $20.69 07/08/2024 Food and Beverage Undisputed 01/23/2026 1131778686 CMS
PFIZER INC. $18.29 07/11/2024 Food and Beverage Undisputed 01/23/2026 1131644865 CMS
PFIZER INC. $19.32 09/05/2024 Food and Beverage Undisputed 01/23/2026 1131844022 CMS
PFIZER INC. $18.52 10/07/2024 Food and Beverage Undisputed 01/23/2026 1131937717 CMS
PFIZER INC. $16.77 10/28/2024 Food and Beverage Undisputed 01/23/2026 1132107004 CMS
PFIZER INC. $20.64 12/16/2024 Food and Beverage Undisputed 01/23/2026 1131190557 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.